Education
About Us
Working with TipRanks
Follow Us
Lifeward (LFWD)
NASDAQ:LFWD
LFWD Stock Chart & Stats
$0.68
-$0.33(-14.93%)
At close: 4:00 PM EST
$0.68
-$0.33(-14.93%)
Day’s Range― - ―
52-Week Range$0.50 - $4.00
Previous CloseN/A
Volume483.00K
Average Volume (3M)316.99K
Market Cap
$12.38M
Enterprise Value$9.45M
Total Cash (Recent Filing)$2.19M
Total Debt (Recent Filing)$237.00K
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Feb 19, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding18,293,776
10 Day Avg. Volume318,606
30 Day Avg. Volume316,993
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.80
Price to Sales (P/S)0.59
P/FCF Ratio-0.69
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue0.39
Enterprise Value/Gross Profit1.03
Enterprise Value/Ebitda-0.59
Forecast
1Y Price Target
$4.50Price Target Upside561.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLifeward's Q4 results showed a gross margin of 45.4%, ahead of the 41.9% expectation.
Market PenetrationManagement plans to expand market penetration of ReWalk Personal among patients covered by Centers for Medicare & Medicaid Services, workers compensation insurance and US commercial insurers.
PartnershipsRecent developments help diversify Lifeward's business through an exclusive partnership with CorLife and an expanded distribution agreement with MYOLYN.
Bears Say
EarningsThe company reported a net loss of $1.73 per share, compared to consensus estimated net loss of $0.31 per share.
Reimbursement DelaysThe company continues to experience longer than expected time to receive CMS reimbursement.
Revenue GuidanceLifeward's FY2025 revenue guidance was mixed, showing lower revenue than forecasted despite a better bottom line.
Lifeward News
LFWD FAQ
What was Lifeward’s price range in the past 12 months?
Lifeward lowest stock price was $0.50 and its highest was $4.00 in the past 12 months.
What is Lifeward’s market cap?
Lifeward’s market cap is $12.38M.
When is Lifeward’s upcoming earnings report date?
Lifeward’s upcoming earnings report date is Feb 19, 2026 which is in 65 days.
How were Lifeward’s earnings last quarter?
Lifeward released its earnings results on Nov 14, 2025. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.2 by $0.01.
Is Lifeward overvalued?
According to Wall Street analysts Lifeward’s price is currently Undervalued.
Does Lifeward pay dividends?
Lifeward does not currently pay dividends.
What is Lifeward’s EPS estimate?
Lifeward’s EPS estimate is -0.08.
How many shares outstanding does Lifeward have?
Lifeward has 18,293,776 shares outstanding.
What happened to Lifeward’s price movement after its last earnings report?
Lifeward reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.2. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Lifeward?
Currently, no hedge funds are holding shares in LFWD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lifeward
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
LFWD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call for Lifeward Ltd. highlighted significant operational improvements and strategic expansions, particularly in the ReWalk product line and European market access. However, challenges remain with declining revenue in the ATLAS G product line and increased operating expenses. The company is optimistic about its transformation and future growth, bolstered by operational efficiencies and financial backing.View all LFWD earnings summariesLFWD Stock 12 Month Forecast
Average Price Target
$4.50
▲(561.76% Upside)
Technical Analysis
Ownership Overview
10.66% Insiders
0.02% Mutual Funds
0.44% Other Institutional Investors
88.88% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---